Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease.

Javier Lozano-Sanroma Alberto Barros Ignacio Alcalde Rosa Alvarado-VillacortaRonald M Sánchez-ÁvilaJuan Queiruga-PiñeiroLuis Fernández-Vega CuetoEduardo Antiua Jesús Merayo-Lloves

Published in: Diseases (Basel, Switzerland) (2024)

The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.

Keyphrases

growth factor
optic nerve
oxidative stress
depressive symptoms
physical activity